# Transseptal vs Retrograde Aortic Ventricular Entry to Reduce Systemic Emboli

> **NCT03946072** · NA · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 153 (actual)

## Conditions studied

- Neurocognitive Dysfunction

## Interventions

- **PROCEDURE:** Transseptal Aortic Approach Catheter Ablation Procedure
- **PROCEDURE:** Retrograde Aortic Approach Catheter Ablation Procedure

## Key facts

- **NCT ID:** NCT03946072
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-02
- **Primary completion:** 2023-11-25
- **Final completion:** 2023-11-25
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2023-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03946072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03946072, "Transseptal vs Retrograde Aortic Ventricular Entry to Reduce Systemic Emboli". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03946072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*